UNSPSC 51285314: Nifurizone

This classification denotes an anti-infective agent with the molecular formula C12H13N5O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 26LO5Z6IHQ, chemically known as 1-imidazolidinecarboxamide, n-methyl-3-((3-(5-nitro-2-furyl)allylidene)amino)-2-oxo- but more generally known as nifurizone, which bears US NIH Compound Identifier 9577579. European Medicines Agency schedules Nifurizone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09267MIG.

UNSPSC 51285314 Nifurizone, a Commodity code, shows minimal recent state and local procurement activity directly aligned with the code's pharmaceutical scope. The single recent opportunity tagged to this code—Seminole County, Florida's IFB 60459723LAS for Naloxone and Drug Deactivation Systems (posted June 30, 2026, response deadline July 26, 2023)—solicits naloxone and safe drug deactivation systems for community health initiatives rather than nifurizone itself. The mismatch between the code's nominal scope and the actual procurement signals either a data-entry error in the tagging or extremely limited use of this specific pharmaceutical code in state and local procurement. Beyond this single misaligned record, the source contains no other opportunities under UNSPSC 51285314.

The Seminole County procurement, while misaligned with the code, does reflect broader state and local activity in pharmaceutical and medical supply contracting—evidenced by parallel solicitations from the City of Tampa (medical and first aid supplies for fire rescue, IFB 26P00145, due March 13, 2026), Texas HHS Commission (pharmacy benefit program innovation, RFI HHS0017013, due April 3, 2026), and Minnesota Multistate Cooperative Purchasing Alliance (generic pharmaceuticals and OTC products via RFP S1070000015802, due March 26, 2026). These parallel activities indicate that state and local governments actively procure pharmaceutical products through cooperative vehicles and direct municipal buys, but UNSPSC 51285314 itself appears dormant or severely underutilized in current state and local contracting. Firms pursuing this code should verify whether the pharmaceutical classification is correctly applied to their offering or consider broader pharmaceutical and medical-supply codes with demonstrated recent activity.